Is Elevance Health (ELV) Entering a Major Earnings Recovery?

Greenskeeper Asset Management's Q2 2026 scorecard highlighted Elevance Health (ELV) as a strong contributor to its portfolio, with the company gaining 32.1% in the quarter. The asset management firm anticipates 2026 will mark the bottom for ELV's operating margins, expecting an earnings recovery in 2027 driven by disciplined repricing and better alignment between premiums and medical expenses. The investment thesis is based on the strength of ELV's commercial health insurance franchise, which provides a durable foundation for long-term earnings.